Business
Nanalysis Wins European Competitive Bid with NextGen MRI System for Personalized Medicine Research
Nanalysis Wins European Competitive Bid with NextGen MRI System for Personalized Medicine...
About this update from Nanalysis Scientific Corp
[{"type":"text","content":"\n \n \n \n Nanalysis Wins European Competitive Bid with NextGen MRI System for Personalized Medicine Research\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n STRASBOURG, France\n \n ,\n \n Dec. 10, 2020\n \n /CNW/ -\n \n Nanalysis Scientific Corp.\n \n (Nanalysis), (\n \n TSXV: NSCI\n \n ) (\n \n OTCQX: NSCIF\n \n ) (\n \n FRA: 1N1\n \n ), through its subsidiary RS2D S.A.S. (RS2D), is pleased to announce that it has won a\n \n C$1.2M\n \n non-repayable grant to further leverage its proprietary Nuclear Magnetic Resonance Imaging (MRI) technology for smart NextGen clinical MRI systems. This product, based on the Cameleon4\n \n TM\n \n Original Equipment Manufacturer (OEM) product, will advance these devices an additional step towards the personalized medicine of the future.\n \n \n Rémy Schimpf, Senior VP Sales states \"We are very pleased to win this competitive project, which is consistent with our strategy to leverage our Nuclear Magnetic Resonance (NMR) spectroscopy technology for MRI applications, which we offer through OEM partnerships. When I founded RS2D 15 years ago, I had a vision to build a family of products in NMR and MRI that use a common technology platform. We are succeeding at this objective. I am extremely proud that our application was selected together with 60 other successful projects out of 902 submissions, by experts at the European Commission (EC), receiving a perfect score of 5 out of 5. The EC evaluators stated in writing that our project has a unique 'Clarity of the radical vision of a science-enabled technology and its differentiation from current paradigms'.\n \n \n This project combines our Cameleon4\n \n TM\n \n technology, used in our benchtop and high-field NMR products, with our NextGen software, in partnership with leaders in personalized medicine and high sensitivity MRI technology such as Haute Ecole Specialisée de Suisse Occidental in\n \n Basel, Switzerland\n \n . MRI is a very powerful and widely used diagnostic technique, but it has a known weakness: Sensitivity. The main objective of this project is to demons...